Caribou Biosciences, Inc.CRBUNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
38.21%
↑ 295% above average
Average (22q)
-19.58%
Historical baseline
Range
High:78.38%
Low:-264.92%
Volatility
-1753.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 38.21% |
| Q2 2025 | -10.87% |
| Q1 2025 | -10.39% |
| Q4 2024 | -1.67% |
| Q3 2024 | 12.10% |
| Q2 2024 | 5.44% |
| Q1 2024 | -22.86% |
| Q4 2023 | -155.87% |
| Q3 2023 | 55.48% |
| Q2 2023 | -5.63% |
| Q1 2023 | -1.76% |
| Q4 2022 | -15.23% |
| Q3 2022 | 6.66% |
| Q2 2022 | -36.34% |
| Q1 2022 | -2.20% |
| Q4 2021 | -9.61% |
| Q3 2021 | -16.61% |
| Q2 2021 | -21.17% |
| Q1 2021 | 13.40% |
| Q4 2020 | -84.87% |
| Q3 2020 | -264.92% |
| Q2 2020 | 78.38% |
| Q1 2020 | 0.00% |